Madrigal Pharmaceuticals, Inc. Revenue 2012–2025
Madrigal Pharmaceuticals, Inc. annual/quarterly revenue history and growth rate from 2012 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Madrigal Pharmaceuticals, Inc. revenue for the quarter ending March 31, 2026 was 311.3 M, a 126.84% increase year-over-year.
- Madrigal Pharmaceuticals, Inc. revenue for the twelve months ending March 31, 2026 was 948.7 M, a 1135.02% increase year-over-year.
- Madrigal Pharmaceuticals, Inc. annual revenue for 2025 was 958.4 M, a 432.05% increase from 2024.
- Madrigal Pharmaceuticals, Inc. annual revenue for 2024 was 180.1 M.
- Madrigal Pharmaceuticals, Inc. annual revenue for 2023 was 0.
- Madrigal Pharmaceuticals, Inc. annual revenue for 2022 was 0.
Madrigal Pharmaceuticals, Inc. (MDGL) — Frequently Asked Questions
Madrigal Pharmaceuticals, Inc. (MDGL) is a publicly traded US company. It has a market capitalization of $10.67B. In fiscal 2025 it reported revenue of $958M and net income of -$288M. Explore MDGL's stock price, financial statements, earnings history, margins and key ratios below.
What is Madrigal Pharmaceuticals, Inc.'s market cap?
Madrigal Pharmaceuticals, Inc. (MDGL) has a market capitalization of $10.67B.
What is the MDGL stock price?
MDGL trades at $475.42 (+0.87% on the day).
How much revenue does Madrigal Pharmaceuticals, Inc. make?
Madrigal Pharmaceuticals, Inc. reported revenue of $958M in fiscal 2025.
Is MDGL profitable?
In fiscal 2025, Madrigal Pharmaceuticals, Inc. reported net income of -$288M.